Albany Gains New Mental Health Resource as Rivia Mind Opens New Office
ALBANY, NEW YORK / ACCESS Newswire / September 23, 2025 / Rivia Mind, a mental health practice providing compassionate, evidence-based...
ALBANY, NEW YORK / ACCESS Newswire / September 23, 2025 / Rivia Mind, a mental health practice providing compassionate, evidence-based...
Additional New Clinical Data To Be Presented Driving a New Standard of Care in Volume Measurement OAK RIDGE, Tenn., Sept....
Strategic collaboration expands CBDL's footprint in the booming East Coast cannabis market projected to surpass $33 billion by 2030, while...
- Patent-pending pre-scan technology enables custom radiation dose tailored to patient’s unique breast size and composition - - Feature aligns...
First and only in-clinic multiplexed Cobalamin & Folate assay now validated for feline patients ANN ARBOR, MI / ACCESS Newswire...
SALT LAKE CITY and BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic...
DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in...
BRISTOL, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Once relegated to the back rooms of hospitals, hypochlorous acid (HOCl) is...
COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:...
McGill University and University of Alberta each awarded $10M to pursue bold research with transformational potential to redefine health outcomes...
BETHESDA, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
Open-label study evaluated a two-dose induction regimen of BPL-003 (8 mg followed by 12 mg two weeks later) in patients...
Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program and unveils new mechanism of action for TEAD degradation...
FRIENDSWOOD, Texas, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that...
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 23, 2025, at 14:00...
Singapore, Singapore--(Newsfile Corp. - September 23, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading AI-powered...
CHICAGO--(BUSINESS WIRE)--Artisight today announced an enterprise-wide agreement with Yale New Haven Health to implement its Smart Hospital Platform. The initial...
Global AI in Oncology For Analytical Solutions Market to Transform Cancer Care Accelerating Early Detection, Precision Treatment, and Patient Outcomes....
RELLINGEN, DE / ACCESS Newswire / September 23, 2025 / Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company...
Hemogenyx Pharmaceuticals Signs Letter of Intent with Cellin Technologies to Advance Commercialization of HG-CT-1 CAR-T Therapy in EstoniaFirst Potential Near-Term...